Largest biotech by market cap

Amgen leads the 24 biotech ranked by market value, at R$1.44T, ahead of Gilead Sciences (R$1.23T) and Moderna (R$486B). Figures as of 18 Nov 2026, 13:00 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenR$1.44T
Median
R$60.2B
Combined market value
R$4.93T
Countries
5

Market values as of .

Largest biotech by market cap
#CompanyMarket cap ↓PriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareR$1.44TR$2,659.75 0.95% down 34% up United States
2Gilead SciencesGILD · Health CareR$1.23TR$988.90 1.60% up 33% up United States
3ModernaMRNA · Health CareR$486BR$1,201.14 3.93% down 755% up United States
4argenxARGX · Health CareR$346.1BR$5,503.39 0.36% down 4% up Belgium
5BiogenBIIB · Health CareR$215.3BR$1,456.64 0.34% down 49% up United States
6Revolution MedicinesRVMD · Health CareR$204.4BR$944.94 2.50% down 131% up United States
7BioNTechBNTX · Health CareR$122.2BR$492.88 0.47% down 16% down Germany
8Neurocrine BiosciencesNBIX · Health CareR$97.5BR$963.70 0.37% up 20% up United States
9ExelixisEXEL · Health CareR$97.1BR$397.86 2.09% up 63% up United States
10Bio-TechneTECH · Health CareR$66.3BR$421.85 0.22% down 26% up United States
11Halozyme TherapeuticsHALO · Health CareR$63.6BR$557.41 0.55% down 37% up United States
12Kymera TherapeuticsKYMR · Health CareR$60.3BR$705.81 3.44% down 87% up United States
13RepligenRGEN · Health CareR$60.2BR$941.97 0.37% down 5% up United States
14QiagenQGEN · Health CareR$59.7BR$288.96 0.12% down 12% up Netherlands
15VaxcytePCVX · Health CareR$54.6BR$345.01 3.59% down 22% up United States
16Krystal BiotechKRYS · Health CareR$51.4BR$1,734.04 0.22% up 46% up United States
17Twist BioscienceTWST · Health CareR$44.4BR$650.52 6.63% up 340% up United States
18CG OncologyCGON · Health CareR$41BR$458.50 6.89% down 85% up United States
19ImmunovantIMVT · Health CareR$39.9BR$192.89 0.21% down 43% up United States
20ImmunityBioIBRX · Health CareR$38.7BR$36.36 4.68% up 193% up United States
21Kodiak SciencesKOD · Health CareR$36.8BR$562.23 3.90% down 396% up United States
22Scholar Rock HoldingSRRK · Health CareR$31.9BR$261.83 1.21% up 14% up United States
23Adaptive BiotechnologiesADPT · Health CareR$26.8BR$165.48 2.22% up 88% up United States
24CRISPR TherapeuticsCRSP · Health CareR$22.6BR$233.20 0.54% down 21% down Switzerland

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 5.8082 BRL).

Questions and answers

Which biotech rank first by market value?

Amgen (R$1.44T), Gilead Sciences (R$1.23T) and Moderna (R$486B) are the top three of the 24 biotech ranked by market value as of 18 Nov 2026, 13:00 UTC.

How many biotech are in this ranking?

24 are ranked by market value.

What are these biotech worth together?

The 24 biotech ranked by market value have a combined market value of R$4.93T as of 18 Nov 2026, 13:00 UTC.

What does ranking by market value measure?

What the stock market values the whole company at: its share price times the number of its shares.

Cite this page

Funkfolio, “Largest biotech by market cap”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech

Underlying data: Yahoo Finance; SEC EDGAR.